secwatch.observer — SEC 8-K summary
======================================

Issuer:     Karyopharm Therapeutics Inc. (KPTI)
CIK:        0001503802
Form:       8-K
Filed at:   2025-01-31T23:59:59+00:00
Accession:  0001193125-25-018385
Event type: other
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Karyopharm grants retention equity awards: 412,500 stock options and 206,250 RSUs to three executives
--------------------------------------------------------------------------------

- Named executives Sohanya Chang, Stuart Poulton, and Reshma Rangwala each receive 137,500 options and 68,750 RSUs, effective Feb 28, 2025.
- Options vest 25% on first anniversary, then monthly over 4 years; RSUs vest 50% on each of two consecutive anniversaries.
- Full acceleration of awards if termination without cause or for good reason occurs within one year after a change-in-control event.
- Exercise price of options equals the closing stock price on the Nasdaq on the grant date.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1503802/000119312525018385/0001193125-25-018385-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1503802/000119312525018385/d914351d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-018385

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer